Fetal and early postnatal environmental exposures and reproductive health effects in the female

image of fetal exposure

DES exposure induces changes in the expression of many genes such as Wnt7a, Hoxa9, Hoxa10, Hoxa11, lactoferrin and c-fos genes

2008 Study Abstracts

Current studies are investigating the possibility that neonatal estrogen exposure may alter activin signaling in the ovary, thereby leading to ovarian pathologies. We have examined the effect of neonatal DES and E2 exposure on the mRNA and protein levels of the key factors involved in activin signaling in the mouse ovary. Preliminary results demonstrate that neonatal estrogen exposure decreases activin subunit gene expression and impacts activin signaling, indicating that activin genes are targets of estrogen action in the mouse ovary. Future studies will further characterize the mechanisms underlying the effects of premature estrogen and activin exposure on adult ovarian and follicular function.

From the 1940s to 1970s, the xenoestogen DES was extensively prescribed to pregnant women at risk for miscarriage. Women exposed to DES in utero during critical periods of reproductive tract development developed several types of reproductive tract abnormalities, as well as an increased incidence of cervical-vaginal cancer later in life. Animal studies that simulate the human DES experience have since shown that exposure of the developing reproductive tract of CD-1 mice to DES imparts a permanent estrogen imprint that alters reproductive tract morphology, induces persistent expression of the lactoferrin and c-fos genes and induces a high incidence of uterine adenocarcinoma. Since DES is readily metabolized and cleared within days after exposure, the persistent alterations resulting from developmental DES exposure cannot simply be explained by residual body burden of the compound. DES exposure also induces changes in the expression of several uterine genes involved in tissue patterning, such as Wnt7a, Hoxa9, Hoxa10 and Hoxa11, contributing to changes in tissue architecture and morphology. DES-induced developmental programming appears to require the estrogen receptor α (ERα), suggesting that signaling through this receptor is crucial for establishing developmental programming. These initial observations with DES firmly established the developmental period as a window of susceptibility during which an inappropriate xenoestrogen exposure can induce developmental programming and increase risk for diseases, including cancer, later in life.

We have recently demonstrated that developmental programming can increase the risk for developing uterine leiomyoma in adulthood the adult. Utilizing rats carrying a germline defect in the tuberous sclerosis complex 2 (Tsc-2) tumor suppressor gene that are predisposed to uterine leiomyomas, we found that an early life exposure to DES during development of the uterus increased risk for uterine leiomyoma from 65% to greater than 90% and increased tumor multiplicity and size in genetically predisposed animals, but failed to induce tumors in wild-type rats. Importantly, we found that DES exposure imparted a hormonal imprint on the developing uterine myometrium in both wild-type and carrier rats, causing an increase in expression of estrogen-responsive genes prior to the onset of tumors. Thus, when developmental programming of estrogen-responsive genes was combined with the presence of the Tsc-2 tumor suppressor gene defect, the result was an increased risk of developing hormone-dependent leiomyoma in adult animals. These data suggest that exposure to environmental factors during development can permanently reprogram normal physiological tissue responses and thus lead to increased tumor suppressor gene penetrance in genetically susceptible individuals. Developmental programming occurred as a result of the hormonal imprint imparted on the developing uterus by the brief early life exposure to DES.

Sources

  • Full study (free access) : Fetal and Early Postnatal Environmental Exposures and Reproductive Health Effects in the Female, Fertility and Sterility, NCBI PubMed PMC2527475, 2008 Feb.
  • Featured image Mel Elías.
DES DIETHYLSTILBESTROL RESOURCES

Developmental reprogramming of cancer susceptibility

image of cancer susceptibility

2012 Study Abstracts

Gene–environment interactions have been traditionally understood to promote the acquisition of mutations that drive multistage carcinogenesis, and, in the case of inherited defects in tumour suppressor genes, additional mutations are required for cancer development. However, the developmental origins of health and disease (DOHAD) hypothesis provides an alternative model whereby environmental exposures during development increase susceptibility to cancer in adulthood, not by inducing genetic mutations, but by reprogramming the epigenome. We hypothesize that this epigenetic reprogramming functions as a new type of gene–environment interaction by which environmental exposures target the epigenome to increase cancer susceptibility.

The developmental origins of health and disease (DOHAD) hypothesis

The developmental origins of health and disease (DOHAD) hypothesis posits that increased risk of disease in adulthood can result from an adverse developmental environment that reprogrammes cellular and tissue responses to normal physiological signals in a manner that increases disease susceptibility.

An example is altered DNA methylation that is observed in the uterus in response to in utero exposure to the xenoestrogen diethylstilbestrol (DES). The adult uterus of an animal exposed to this xenoestrogen in utero exhibits alterations in the methylation of the lactotransferrin (Ltf) gene after puberty. If ovariectomized, the aberrant DNA methylation that is observed in intact animals is not observed in the castrated female uterus. Similarly, early life exposure to DES or to the phytoestrogen genistein can reprogramme high-mobility group nucleosome-binding domain 5 (Hmgn5; also known as Nsbp1) gene methylation, causing the promoter of this gene to become hypomethylated in the adult uterus, which increases gene expression.

Mechanisms of epigenetic reprogramming

If developmental exposures are reprogramming the epigenome to increase susceptibility to diseases such as cancer, the effects of this reprogramming should be apparent in the ‘normal’ tissue prior to the development of disease. Ample evidence exists that developmental reprogramming induces epigenetic changes that can be detected in at-risk tissues prior to the development of tumours. In the reproductive tract, examples of genes in which developmental reprogramming induces persistent alterations in DNA methylation include FOS, LTF , homeobox A10 (HOXA10), HMGN5 and phosphodiesterase 4D variant 4 (PDE4D4). Early studies demonstrated that neonatal DES exposure induced aberrant methylation of specific CpG sites in Ltf and Fos in the mouse uterus. More recently, developmental exposure to several endocrine-disrupting compounds (EDCs), including xenoestrogens, was found to modulate the expression and promoter methylation of HOX genes, which have key roles in uterine development. Exposure to DES in utero results in increased promoter methylation and decreased HOXA10 expression, whereas bisphenol A (BPA) exposure results in decreased methylation of HOXA10, increased oestrogen receptor (ER) binding by HOXA10 and increased HOXA10 expression in the adult uterus.

Similarly, neonatal exposure of mice to DES or genistein also induces persistent hypomethylation of the Hmgn5 promoter and aberrant overexpression of this gene in the uterus throughout life, and exposure is associated with an increased risk of developing uterine tumours in adult female mice.

Early life environmental exposures and reproductive tract cancer

The xenoestrogen DES, a synthetic stilbene oestrogen, was administered to pregnant women from the 1940s to the 1970s to prevent complications of pregnancy. In the early 1970s, the daughters of women who took DES during the first trimester (so-called ‘DES daughters’) were frequently diagnosed with congenital reproductive tract abnormalities (specifically, a ‘T-shaped’ uterus), dysplasia and cervical intraepithelial neoplasia, and with a significantly increased rate of an otherwise rare type of vaginal clear cell adenocarcinoma. Continued follow-up of DES daughters has now revealed that they also have an increased relative risk for developing breast cancer (~twofold to threefold that of unexposed women) and uterine leiomyoma, although not all data on this point are concordant. DES sons may also be at a higher risk of developing prostate cancer; however, the final verdict on this point requires additional investigation.

Animal studies that simulate the human DES experience show that exposure of the developing reproductive tract to DES and other xenoestrogens imparts a permanent oestrogen imprint that alters reproductive tract morphology, induces persistent expression of oestrogen-responsive genes and induces a high incidence of uterine adenocarcinoma. Uterine leiomyoma, sometimes referred to as fibroids, arise from the smooth muscle layer of the uterus and are the most common benign tumour in women. In rats carrying a genetic defect in the tuberous sclerosis 2 (Tsc2) tumour suppressor gene, exposure to DES during uterine development causes the tumour suppressor defect to become fully penetrant, increasing tumour incidence from 65% to 100% (discussed below). This increased penetrance is associated with the reprogramming of oestrogen-responsive genes, which become hyper-responsive to hormone and promote the development of hormone-dependent uterine leiomyomas. DES exposure during this crucial perinatal period of development also modulates IGF signalling in the adult endometrium, decreasing negative feedback to insulin receptor substrate 1 (IRS1) and increasing the incidence of endometrial hyperplasia in rats that are genetically predisposed to develop these preneoplastic lesions.

Inappropriate exposure to environmental oestrogens, such as DES, the plasticizor BPA or the soy phytoestrogen genistein, during mammary gland development alters the susceptibility of the mammary gland to chemical carcinogenesis in adulthood. The mammary gland begins developing in utero and is not fully mature until after pregnancy and lactation. Importantly, the effect of xenoestrogen exposure during mammary gland development differs throughout life. Xenoestrogen exposure in utero can increase the risk for mammary tumorigenesis, in part by altering mammary gland architecture and increasing the number of target cells for transformation in terminal end buds (TEBs) of the mammary gland. Conversely, xenoestrogen exposure during the postnatal period can decrease susceptibility to mammary gland tumorigenesis by inducing a programme of differentiation in mammary epithelial cells that mimics the protective effects of pregnancy. In addition to xenoestrogen exposure, there is a suggestion that prenatal famine may increase breast cancer incidence in exposed individuals.

Testicular cancer, one of the features of testicular dysgenesis syndrome (TDS), which includes poor semen quality, undescended testis and hypospadias, has also been linked to early life environmental exposures. Experimental studies from animal models and human epidemiology support a causal association between TDS and exposure to compounds that disrupt the endocrine system, such as DES, and anti-androgens, such as vinclozolin, during male reproductive tract development. In humans, the majority of testicular cancers are derived from germ cells, and epidemiology data suggest in utero DES exposure may be a risk factor. Testicular cancer is preceded by carcinoma in situ, and recent studies suggest that these lesions have a gene expression pattern that is similar to gonocytes (spermatogonia) and exhibit DNA hypomethylation and altered methylation of histones H3K9, H3K27 and H3K4, which is analogous to the epigenetic pattern that is seen in fetal germ cells. These data have led to the suggestion that germ cells in the developing testis are the target for the developmental reprogramming that is associated with TDS.

The maternal environment might also play a part in susceptibility to testicular cancer. Low birth weight is a risk factor for testicular germ-cell cancer (which comprises more than 95% of testicular cancer), and a recent meta-analysis of 18 epidemiological studies indicated that low birth weight is also a risk factor for testicular cancer. Although germ-cell testicular cancer is very rare in experimental animal models, by contrast, interstitial cancers, benign tumours and adenocarcinoma of the rete testis are frequently observed in rodent testes that have been prenatally exposed to DES. In the prostate, early life exposure of rodents to xenoestrogens such as methoxychlor, BPA or genistein leads to prostate hypertrophy and increased inflammation with age in the prostate of adult animals and can also predispose to prostate carcinogenesis.

A new gene–environment interaction?

Studies in Eker rats with a defect in Tsc2 first pointed to the fact that exposure to environmental oestrogens during development could cooperate with a tumour suppressor gene defect to increase the penetrance of the defective tumour suppressor gene. In this model, brief neonatal exposure to environmental oestrogens, such as DES, during uterine development significantly increased tumour incidence (that is, penetrance), as well as tumour multiplicity and size. Neonatal xenoestrogen exposure also resulted in the reprogramming of oestrogen-responsive gene expression, which manifested as an increased expression of oestrogen-responsive genes in the adult myometrium at 5 months of age, many months prior to tumour development. This suggests that the combined increase in oestrogen responsiveness (reprogramming) and the defect in Tsc2 promoted the development of hormone-dependent leiomyoma, effectively increasing tumour suppressor gene penetrance. Importantly, in the absence of the tumour suppressor gene defect, environmental oestrogen exposure alone failed to induce tumours, even though gene expression was reprogrammed (K. L. Greathouse and C.L.W., unpublished observations). Conversely, ovariectomy almost completely ablated tumour development in genetically predisposed animals, indicating that, in the absence of ovarian hormones, the tumour suppressor gene defect was not sufficient to induce tumorigenesis. Thus, developmental reprogramming can cooperate with a tumour suppressor gene defect to increase its penetrance, thereby functioning as a new type of gene–environment interaction.

As a result of this developmental reprogramming, oestrogen-responsive genes in the uterus become hyper-sensitive to hormone, which promotes tumour development in adult animals that are neonatally exposed to environmental oestrogens. In Eker rats that are neonatally exposed to DES, more than 50% of the oestrogen-responsive genes that have been examined in the adult uterus displayed an inappropriate, exaggerated response to steroid hormones: reprogrammed genes were overexpressed during the oestrus cycle when oestrogen levels were high, and remained elevated even during periods of the oestrous cycle when hormones were at their lowest. As a result, the uterus displayed an ‘oestrogenized phenotype’ that cooperated with the tumour suppressor gene defect to increase tumour suppressor gene penetrance. Together, these data lead us to propose that developmental reprogramming is a type of gene–environment interaction that can cooperate with a genetic predisposition, not by inducing mutations, but by reprogramming the epigenome to modulate gene expression in order to promote tumour development.

Sources

  • Full study (free access) : Developmental reprogramming of cancer susceptibility, Nat Rev Cancer, NCBI PubMed, PMC3820510, 2012 Jun 14.
  • Featured image Ken Treloar.
DES DIETHYLSTILBESTROL RESOURCES

Epigenetics, Evolution, Endocrine Disruption, Health, and Disease

image of Epigenetics, Evolution, Endocrine Disruption, Health, and Disease

A possible mechanism for how DES exerts its action epigenetically has been proposed recently

2006 Study Abstracts

Endocrine-disrupting chemicals (EDCs) in the environment have been linked to human health and disease. This is particularly evident in compounds that mimic the effects of estrogens. Exposure to EDCs early in life can increase risk levels of compromised physical and mental health. Epigenetic mechanisms have been implicated in this process. Transgenerational consequences of EDC exposure is also discussed in both a proximate (mechanism) and ultimate (evolution) context as well as recent work suggesting how such transmission might become incorporated into the genome and subject to selection. We suggest a perspective for exploring and ultimately coming to understand diseases that may have environmental or endocrine origins.

That epigenetic mechanisms may play a role in endocrine disruption helps explain the transgenerational effects of some hormonally active chemicals. Treatment with diethylstilbestrol (DES) during pregnancy results in vaginal adenocarcinoma in female offspring in humans and mice. Female offspring of mice exposed to DES during pregnancy, when mated to control males, produce a second generation of females who, although not exposed to DES themselves, express this same rare genital tract cancer. This transgenerational transmission of a specific reproductive tract lesion would be hard to explain without invoking an epigenetic mechanism for heritable change and, given the finding of altered DNA methylation patterns in a specific uterine gene in mice treated developmentally with DES, we think a strong case can be made for such a conclusion. Newbold and colleagues next showed that specific, rare genital tract cancers (rete testes cancers) are also expressed and therefore transmitted to the male offspring of females treated in utero with DES. In colloquial terms, this demonstrated the occurrence of reproductive tract tumors in the grandsons and granddaughters of mothers treated with DES. A possible mechanism for how DES exerts its action epigenetically has been proposed recently. The transmission of uniquely specific changes in the program of development in mice has implications for similarly exposed humans as well as the biology of hormonally induced disease.

We have already mentioned that DES treatment of mice during development results in reproductive tract cancers, persistent up-regulation of key estrogen-responsive genes, and altered patterns of gene methylation in the affected genes and that the cancer can be transmitted through two generations. In addition to DES, methoxychlor has been reported to increase global DNA methylation in uterine ribosomal DNA after in utero exposure; the alteration in methylation remains months after treatment.

To understand the role of estrogens in development, there is hardly a more powerful model than that of the outcomes observed in humans and mice developmentally exposed to the synthetic estrogen DES. Female offspring of humans or mice exposed prenatally to DES have a risk for vaginal clear cell adenocarcinoma. The mechanisms underlying these developmentally induced lesions have been sought for three decades. There was the suggestion by clinical investigators that DES had altered the normal differentiation of the epithelial cells of the fetal cervix and vagina such that they responded abnormally to estrogen at puberty, because no cancers had been seen in prepubescent girls. Similarly, ovariectomy of developmentally DES-treated mice prevented the subsequent expression of uterine adenocarcinomas.

Epigenetic change in the molecular program of cell differentiation in the affected tissues may be a common mechanism. The clear cell cancers of the vagina in DES-exposed women displayed genetic instability consistent with epigenetic imprints in the absence of any expected mutation in classical oncogenes or tumor suppressor genes. Using a well validated mouse model for DES genital tract tumors, Li and colleagues discovered that one of the estrogen-inducible genes in the mouse uterus, lactotransferrin, that had been shown earlier to be persistently up-regulated by developmental DES exposure, had an altered pattern of CpG methylation in the promoter region of the gene upstream from the estrogen response element. Subsequent work demonstrated that other developmentally up-regulated genes such as fos and jun also had persistent changes in the pattern of methylation of the gene after DES exposure during development. These experiments raise the possibility that DES (and other environmental estrogens) alter the program of differentiation of estrogen target cells in the reproductive tract through an epigenetic mechanism.

Other studies support this hypothesis. In addition to cervicovaginal adenocarcinomas in female mice and humans exposed prenatally to DES and uterine adenocarcinoma in mice, it has been shown that developmental exposure to DES results in excess risk of uterine leiomyomas (fibroids) in mice, rats, and women. It was also recently reported that sea lions in areas contaminated with EDCs have a higher prevalence of uterine fibroids. The Eker rat carries a germ-line mutation in a tumor suppressor gene and is predisposed to uterine leiomyoma. Cook and colleagues used this model system to demonstrate a DES-induced alteration in developmental imprinting as analyzed by tumor suppressor gene penetrance, concluding that developmental programming by estrogen works in concert with preexisting genetic change. In a population of 819 black and 504 white women, fibroid status was determined by ultrasound screening or surgical record review, whereas prenatal DES exposure was determined by interview. DES-exposed women had a significantly greater risk for uterine fibroids and tended to have larger tumors. The authors conclude that their study, as well as animal studies, indicate a role for prenatal estrogen in the etiology of uterine leiomyoma in women.

Sources

  • Full study (free access) : Epigenetics, Evolution, Endocrine Disruption, Health, and Disease, Endocrinology, Volume 147, Issue 6, Pages s4–s10, doi.org/10.1210/en.2005-1122, June 2006.
  • Featured image academic.oup.
DES DIETHYLSTILBESTROL RESOURCES

Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes

image of Environmental Epigenetics

2012 Study Abstracts

Introduction

This review focuses on how environmental factors through epigenetics modify disease risk and health outcomes. Major epigenetic events, such as histone modifications, DNA methylation, and microRNA expression, are described. The function of dose, duration, composition, and window of exposure in remodeling the individual’s epigenetic terrain and disease susceptibility are addressed. The ideas of lifelong editing of early-life epigenetic memories, transgenerational effects through germline transmission, and the potential role of hydroxylmethylation of cytosine in developmental reprogramming are discussed. Finally, the epigenetic effects of several major classes of environmental factors are reviewed in the context of pathogenesis of disease. These include endocrine disruptors, tobacco smoke, polycyclic aromatic hydrocarbons, infectious pathogens, particulate matter, diesel exhaust particles, dust mites, fungi, heavy metals, and other indoor and outdoor pollutants. We conclude that the summation of epigenetic modifications induced by multiple environmental exposures, accumulated over time, represented as broad or narrow, acute or chronic, developmental or lifelong, may provide a more precise assessment of risk and consequences. Future investigations may focus on their use as readouts or biomarkers of the totality of past exposure for the prediction of future disease risk and the prescription of effective countermeasures.

Implications of Lifelong Editing of Early-Life Epigenetic Memories

The concept of continued editing of early-life epigenetic markings or memories during adult life has been proposed on the basis of evidence from limited experimental studies. Exposure of mice to diethylstilbestrol (DES, a xenoestrogen) or genistein (a phytoestrogen) during the perinatal period induced specific epigenetic markings in their uteri. However, some of these epigenetic markings (hypomethylation of Nsbp1) remained “hidden” during prepuberty life and appeared in adulthood only in the exposed intact females but not in their ovariectomized counterparts, suggesting that adult exposure to ovarian steroids may cause these markings to “surface.” Coincidentally, the prevalence of uterine cancer was higher in neonatally exposed intact mice, but not in mice ovariectormized before puberty.

Epigenetic Factors Shown to Trigger Epigenetic Events and Affect Disease States

Exposure to EDCs during early developmental periods is a major health concern because it can cause persistent changes in gene expression through epigenetic reprogramming in somatic cells, as well as germ-line cells, and subsequently promote transgenerational inheritance. The xenoestrogen DES was widely used in cattle and other livestock industries and is still an EDC in many populations. Early-life exposure of mice to DES increases risk of uterine cancer that is accompanied by demethylation of an estrogen-responsive gene, lactoferrin, in the mouse uterus. In utero exposure of mice to DES triggered hypermethylation of the homeobox A10 with attended uterine hyperplasia and neoplasia in later life. A more recent report documented hypermethylation of nucleosome binding protein 1 (Nsbp1 or Hmgn5) as a hidden uterine epigenetic mark after neonatal DES exposure that only appeared upon sexual maturation of the exposed mice but failed to manifest if the animals were ovarietomized before puberty. Of significant interest is the transgenerational effect of developmental exposure of mice to DES that promoted c-fos expression, hypomethylation of specific exon CpGs, and increased susceptibility to tumorigenesis in the F2 generation. These experimental data support the hypothesis that epigenetic reprogramming is responsible for the devastating consequences observed in the offspring of women who took DES during pregnancy. The DES effects include female genital abnormalities, vaginal cancer, and male urogenital disorders. The adverse effects may be reverberating in the grandchildren of these women.

Sources

  • Full study (free access) : Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes, ILAR Journal, NCBI PubMed PMC4021822, 2012 Dec.
  • Featured image by h heyerlein.
DES DIETHYLSTILBESTROL RESOURCES

Transgenerational Epigenetic Inheritance: Focus on Endocrine Disrupting Compounds

image of transgenerational-epigenetic-inheritance

2014 Study Abstract

The classic case of an EDC is diethylstilbestrol (DES), an estrogen agonist and androgen receptor antagonist synthesized first in the 1930s and prescribed to at least 5 million women at risk for miscarriage or experiencing other reproductive problems, from 1938 up to 1975. Instead of the desired effects, use of this compound lead to increased incidence of breast, vaginal, and cervical cancers.

In addition, maternal exposure has documented adverse affects on daughters. These include the same types of cancers as well as a variety of difficulties conceiving and maintaining pregnancies, reproductive tract malformations, abnormal menstrual cycles, early puberty, and behavioral issues. The vast variety of effects is probably related to complexities introduced by the timing of DES treatment and doses. For example, a recent large study of women exposed prenatally to DES revealed a strong correlation between DES, particularly in the first trimester, and noncancerous uterine fibroids. Offspring of rodents exposed to DES during pregnancy recapitulate many of these effects.

Although the initial clinical studies were limited to female offspring, correlations between DES exposure and hypospadias, cryptorchidism, and testicular cancer have been reported in F1 and F2 sons and grandsons of women given DES. Analyses of the clinical studies suggest that the male reproductive illnesses are related to but not necessarily caused by estrogen actions. An alternative hypothesis is that DES produces low-birth-weight babies, and these infants are more prone to testicular dysgenesis syndrome. Multigenerational work in mice has demonstrated that high, but clinically relevant, doses of DES increase the incidence of uterine and other reproductive tract tumors in females and lesions in the male rete testes in F2 offspring. Few data on the critical F3 generation in humans are available nor are there experimental data from rodent models.

EDCs, such as DES, share many properties with steroid hormones: they act at low doses (picograms) and can act in a nonmonotonic manne. Like hormones, they are particularly effective during development, at which time they can modify the course of reproductive tract and brain development. Importantly, the EDCs are more promiscuous than steroids and bind to a larger variety of receptors than normal ligands, albeit with reduced affinities.

Sources

  • Transgenerational Epigenetic Inheritance: Focus on Endocrine Disrupting Compounds, Endocrinology, NCBI PubMed PMC4098001, 2014 Aug.
  • Featured image Matt Artz.
DES DIETHYLSTILBESTROL RESOURCES

Mise au point des connaissances en 2002

image de connaissances

Thesis, Walter-Kull Agnès, June 2002

Abstract

Le diéthylstilbestrol (Distilbène®) était le premier oestrogène de synthèse nonstéroïdien à apparaître sur le marché français en 1950. Son utilisation s’imposait d’abord aux USA à la suite des travaux menés par Smith dans le cadre de la prévention de certaines complications de la grossesse.

Après 25 ans d’utilisation, Herbst découvrait que le diéthylstilbestrol était responsable d’adénocarcinomes vaginaux à cellules claires chez les filles exposées in utero.

Après avoir retracé les principales étapes de « l’affaire Distilbène® » et rappelé les principales propriétés pharmacologiques de la molécule, l’ensemble des effets secondaires lié à l’utilisation du diéthylstilbestrol est abordé. Un cas clinique vient illustrer ces propos en exposant une malformation utérine (utérus en T) chez une jeune femme consultant pour stérilité secondaire et ayant été exposée au diéthylstilbestrol in utero. Une augmentation du risque de cancer du sein chez les mères traitées pendant leur grossesse est en outre rapporté ainsi qu’un nombre accru de malformations uro-génitales chez les garçons exposés in utero.

L’ensemble de ces données a amené le corps médical et paramédical à préconiser une prise en charge gynécologique, obstétricale et médico-psychologique de la population exposée. En 2002, soit 25 ans après l’interdiction de son utilisation chez la femme enceinte, de nouvelles données apparaissent et on parle pour la première fois d’une transmission transgénérationnelle des effets secondaires du médicament.

Sources

Le Distilbène DES, en savoir plus

Cognitive Ability and Cerebral Lateralisation in Transsexuals

image of transsexual

1998 Study Abstracts

It is still unclear to what extent cross-gender identity is due to pre- and perinatal organising effects of sex hormones on the brain. Empirical evidence for a relationship between prenatal hormonal influences and certain aspects of gender typical (cognitive) functioning comes from pre- and postpubertal clinical samples, such as women suffering from congenital adrenal hyperplasia and studies in normal children.

In order to further investigate the hypothesis that cross-gender identity is influenced by prenatal exposure to (atypical) sex steroid levels we conducted a study with early onset, adult male-to-female and female-to-male transsexuals, who were not yet hormonally treated, and nontranssexual adult female and male controls. The aim of the study was to find out whether early onset transsexuals performed in congruence with their biological sex or their gender identity.

The results on different tests show that gender differences were pronounced, and that the two transsexual groups occupied a position in between these two groups, thus showing a pattern of performance away from their biological sex. The findings provide evidence that organisational hormonal influences may have an effect on the development of cross-gender identity.

… … For this reason, DES-exposed males and females provide a valuable opportunity for investigating possible influences of a synthetic estrogen on hemispheric specialization. In a study of cognitive abilities and functional asymmetry in DES-exposed women and their unexposed sisters, the influence of DES on verbal, visuospatial and dichotic listening tasks was investigated. Subjects for this study included 25 right-handed women exposed to DES for at least 5 months prenatally (with 3 of those months occurring during the second trimester when human sexual differentiation is believed to occur), and their unexposed sisters who served as controls. … …

Sources

DES DIETHYLSTILBESTROL RESOURCES

The psychological impact of prenatal DES exposure in women

image of long-term-psychological-impact

A comparison of short-term and long-term effects

1988 Study Abstract

The psychological impact of knowledge of DES exposure on young women was evaluated and compared for 3 time points:

  1. following the disclosure of their DES exposure,
  2. following their first DES-related examination (both retrospectively),
  3. and at the time of the interview.

Sixty DES-exposed daughters described their reactions and worries at each time point in the context of a semi-structured open-ended interview. Results showed:

  1. The majority of women initially reacted with mild to moderate levels of distress and were worried about, in descending order:
    – the cancer risk,
    – potential pregnancy problems,
    – and the effect on their sex life.
  2. The DES exam served to reduce worry in all major areas of concern and represents the time at which the women felt least distressed about issues related to the DES exposure.
  3. Surprisingly, there has been an increase in distress from the time following the first exam to the present. Present levels of distress and worries among women in our sample nearly equalled those reported at the time of disclosure, a period on average of 6.5 years ago. The focus of worries, however, has changed from the cancer risk to worries about pregnancy difficulties, with the additional categories of fear of effects on their children and on themselves as they grow older (e.g., during menopause).

These self-reports indicate that there are long-term worries and distress related to DES exposure. It is also noted that the women’s self-report of level of distress is consistent with difficulties noted by interviewers concerning the women’s general current psychological functioning as measured by the Global Assessment Scale (GAS) and concerning their history of depression as evaluated by the Schedule for Affective Disorders and Schizophrenia, Lifetime Version (SADS-L).

Sources

  • The psychological impact of prenatal DES exposure in women: a comparison of short-term and long-term effects, Journal of Psychosomatic Obstetrics & Gynecology, doi.org/10.3109/01674828809016783, 1988.
  • Featured image Toa Heftiba.
DES DIETHYLSTILBESTROL RESOURCES